Numinus to Participate in Wonderland: Miami on November 3-5, 2022

Small Pharma Receives Approval for First-In-Human Phase I Clinical Trial With...

Psychedelic Bulletin #121: The State of Psychedelic Economy and Industry; Dispatch...

Numinus Launches Psychedelic-Assisted Therapy for Chronic and Serious Medical Illness

PT368 – Ketamine, Group Work, and the Power of Just Being...

COMPASS Pathways plc to announce third quarter 2022 financial results on...

HAVN Life Announces Retail Listing With Loblaws Company Ltd.

Mindset Pharma Announces Poster Presentations at Two Upcoming Scientific Conferences

MINDCURE Announces Financial Results for the First Quarter of Fiscal 2023USA...

Silo Pharma to Discuss Mainstream Pharma and Psychedelics at Wonderland Miami...

Load more